SF3B1 and myeloid neoplasm: Gene mutations in myeloid neoplasms affect a number of cellular pathways, including epigenetic modification (ASXL1, DNMT3A, EZH2, IDH1, IDH2, TET2), RNA splicing (SF3B1, SRSF2, U2AF1, ZRSR2), transcriptional regulation (CEBPA, ETV6, PHF6, RUNX1, TP53, WT1), and proliferative signaling pathways (FLT3, JAK2, KRAS, NRAS).